{"id":"W2248974608","doi":"10.1200/jco.2009.27.15_suppl.10012","title":"Phase I study of sorafenib in children with refractory solid tumors: A Children's Oncology Group Phase I Consortium trial","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Sorafenib; Rash; Internal medicine; Refractory (planetary science); Gastroenterology; Renal cell carcinoma; Neutropenia; Mucositis; Pharmacokinetics; Hepatocellular carcinoma; Toxicity","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001639049,0.00103814,0.001309015,0.0002186499,0.0003572001,0.0007139147,0.0006393068,0.0009959571,0.002623149],"category_scores_gemma":[0.001123416,0.0003134574,0.0007001541,0.0004635832,0.000771502,0.0004180809,0.0003550718,0.002979898,0.0005517143],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001303472,"about_ca_system_score_gemma":0.003264987,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002385085,"about_ca_topic_score_gemma":0.004757793,"domain_scores_codex":[0.9995927,0.0002152251,0.00001915336,0.00005748767,0.00005018134,0.00006522959],"domain_scores_gemma":[0.9987743,0.000176649,0.0002567662,0.00006937017,0.00008702993,0.0006357552],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5859314,0.05923356,0.06473912,0.002505982,0.00283829,0.002111496,0.001082413,0.008110992,0.06549645,0.001720138,0.05595965,0.1502705],"study_design_scores_gemma":[0.7692431,0.1644942,0.03823114,0.0001455385,0.0006062995,0.001558617,0.0001325879,0.002425106,0.005719896,0.0003558794,0.01704206,0.00004549241],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9894872,0.002413785,0.000475425,0.001070155,0.00009144367,0.002356253,0.002082159,0.00007978703,0.001943835],"genre_scores_gemma":[0.9772468,0.002939172,0.003459254,0.002086755,0.0001914776,0.005212715,0.006348748,0.00005887166,0.002456183],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002623149,"threshold_uncertainty_score":0.009457469,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08539427579535198,"score_gpt":0.49273625971611,"score_spread":0.407341983920758,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}